MetLife Investment Management’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-9,054
Closed -$326K 2348
2020
Q4
$326K Hold
9,054
﹤0.01% 1712
2020
Q3
$254K Hold
9,054
﹤0.01% 1713
2020
Q2
$392K Buy
9,054
+6,274
+226% +$284K ﹤0.01% 1513
2020
Q1
$106K Buy
+2,780
New +$108K ﹤0.01% 2044

MetLife Investment Management's VIE Position: Q1 2021 in Review

MetLife Investment Management sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 9,054 shares — an estimated $326K sold.

MetLife Investment Management first reported a position in VIE in Q1 2020 and held it in 4 quarters. The position peaked at $392K in Q2 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

  • MetLife Investment Management reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • MetLife Investment Management sold 9,054 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $326K.
  • MetLife Investment Management first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • MetLife Investment Management's Viela Bio, Inc. Common Stock position peaked at $392K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.